Genomes and Genes

Species

Steven K Burke

Summary

Publications

  1. Hye R, Peden E, O Connor T, Browne B, Dixon B, Schanzer A, et al. Human type I pancreatic elastase treatment of arteriovenous fistulas in patients with chronic kidney disease. J Vasc Surg. 2014;60:454-461.e1 pubmed publisher
    ..PRT-201 appeared safe. The primary efficacy end point was not met. However, both PRT-201 doses were associated with improved unassisted maturation. The 30-?g dose was associated with increased PP in the subset with RCF. ..
  2. Peden E, O Connor T, Browne B, Dixon B, Schanzer A, Jensik S, et al. Arteriovenous fistula patency in the 3 years following vonapanitase and placebo treatment. J Vasc Surg. 2017;65:1113-1120 pubmed publisher
    ..Vonapanitase 30 ?g decreased the rate of procedures to restore or to maintain patency in the analysis that included all patients and in the subset with radiocephalic fistulas. ..